Actual results could differ materially from those currently anticipated
due to a number of risks and uncertainties. Risks and uncertainties related to the acquisition of King by Pfizer that could cause results to differ from expectations include: uncertainties as t
o the timing of the merger; the possibility that a governmental entity may prohibit or delay the consummation of the merge
r; and the risk of shareholder litigation, includi ...[+++]ng the disposition of currently pending litigation, in connection with the merger.